Amylin Upgrade Soar (AMLN)

Posted in pre-market 
November 24th, 2009

Amylin Pharmaceuticals, Inc. (NASDAQ: AMLN) was raised to overweight this morning by BGarclays as seen in our top ten analyst calls.  Apparently, shares are taking it to heart immediately.  At 8:18 AM EST we have seen 50,000 shares trade hands, yet shares are up over 10% at $13.80 after a $12.47 close.  The average volume is 2.7 million shares and the 52-week trading range is $5.92 to $15.69.


Comments are closed